BDNF and myeloid sarcoma: Given the absence of research investigating the influence of this nutrient on both BDNF and hs‐CRP serum levels in patients with MS, the current study seeks to examine the effects of n‐3 fatty acid supplementation on serum levels of BDNF and hs‐CRP, as well as on physical activity and chronic fatigue in individuals with MS.